30 Apr 2025 ADOCIA Announces the Release of its Universal Registration Document for the Year 2024 Icon check
28 Apr 2025 ADOCIA to Present New Data on AdoShell® at Upcoming Scientific Conferences – Showcasing Potential Curative Treatment for Type 1 Diabetes Icon check
17 Apr 2025 ADOCIA Announces Full Year 2024 Financial Results and Provides a Corporate and Financial Update Icon check
11 Apr 2025 Number of Shares and Voting Rights of ADOCIA as of March 31st, 2025 Icon check
14 Mar 2025 Number of Shares and Voting Rights of ADOCIA as of February 28th, 2025 Icon check
28 Feb 2025 ADOCIA Announces the Settlement-Delivery of its €9.7 Million Private Placement Icon check
26 Feb 2025 ADOCIA Announces the Successful Completion of a €9.7 Million Private Placement, Extending its Cash Runway to Q2 2026 Icon check
25 Feb 2025 ADOCIA Reports Fourth Quarter 2024 Financial Results and Provides a Business Update Icon check
14 Feb 2025 Number of Shares and Voting Rights of ADOCIA as of January 31st, 2025 Icon check
22 Jan 2025 ADOCIA Announces Half-Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets Icon check
17 Jan 2025 Number of Shares and Voting Rights of ADOCIA as of December 31st, 2024 Icon check
23 Dec 2024 ADOCIA Announces Its Participation at Upcoming Investor Conferences in 2025 Icon check
19 Dec 2024 ADOCIA Announces its Financial Calendar for 2025 Icon check
12 Dec 2024 ADOCIA and Tonghua Dongbao Announce the Final Dosing in a Phase 3 Clinical Study of BioChaperone® Lispro, Milestone Associated with a $10 Million Payment Icon check
04 Dec 2024 Number of Shares and Voting Rights of ADOCIA as of November 30th, 2024 Icon check
08 Nov 2024 Number of Shares and Voting Rights of ADOCIA as of October 31st, 2024 Icon check
Olivier Soula – Bourse et Valeurs, Lyon Pole Bourse 2024 (FR)
30 Oct 2024 ADOCIA Reports Third Quarter 2024 Financial Results and Provides a Business Update Icon check
15 Oct 2024 ADOCIA announces patenting stable combinations of GLP-1 and amylin analogs for the treatment of obesity and diabetes using its BioChaperone® platform Icon check
08 Oct 2024 Number of Shares and Voting Rights of ADOCIA as of September 30th, 2024 Icon check
23 Sep 2024 ADOCIA Announces Appointment of Mathieu William Gilbert as Chief Financial Officer Icon check
20 Sep 2024 Number of Shares and Voting Rights of ADOCIA as of August 31st, 2024 Icon check
19 Sep 2024 ADOCIA Announces First Half 2024 Financial Results and Provides a Business Update Icon check
30 Aug 2024 Number of Shares and Voting Rights of ADOCIA as of July 31st, 2024 Icon check
29 Aug 2024 ADOCIA to Deliver Oral Presentations on AdoShell® and AdoGel® at EASD Annual Meeting Icon check
24 Jul 2024 ADOCIA Reports Second Quarter 2024 Financial Results and Provides a Business Update Icon check
19 Jul 2024 ADOCIA Announces Half year report on Adocia’s liquidity agreement with Kepler Capital Markets Icon check
11 Jul 2024 Number of Shares and Voting Rights of ADOCIA as of June 30th, 2024 Icon check
Web Conference – BioChaperone Combo – July 2024 (FR)
10 Jul 2024 ADOCIA Announces that Tonghua Dongbao is Discontinuing one of the two Partnership Programs: BioChaperone® Combo Icon check
18 Jun 2024 ADOCIA Announces Three Presentations at the American Diabetes Association 84th Scientific Sessions Icon check
17 Jun 2024 Number of Shares and Voting Rights of ADOCIA as of May 31 st, 2024 Icon check
06 Jun 2024 ADOCIA confirms its eligibility for the PEA–PME Icon check
03 Jun 2024 ADOCIA Announces Appointment of Mathieu William Gilbert as Chief Operating Officer Icon check
Interview Olivier Soula – La France de Demain, Radio Classique – May 2024 (FR)
23 May 2024 ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 13th, 2024 in Paris Icon check
15 May 2024 Number of shares and voting rights of ADOCIA as of April 30th, 2024 Icon check
14 May 2024 ADOCIA Reports First Quarter 2024 Financial Results and Provides a Business Update Icon check
Olivier Soula – LSX World Congress – April 2024
29 Apr 2024 ADOCIA Announces the Release of its Universal Registration Document for the Year 2023 Icon check
24 Apr 2024 ADOCIA Announces Full Year 2023 Financial Results and Provides a Corporate and Financial Update Icon check
12 Apr 2024 Number of shares and voting rights of ADOCIA as of March 31st, 2024 Icon check
Interview Olivier Soula – Le Journal des Biotechs – March 2024 (FR)
21 Mar 2024 ADOCIA Announces a €2 Million Fundraising from its two Main Shareholders and a Member of its Management, and the Signature of an Equity Financing Line with Vester Finance Icon check
BIO-Europe Spring 2024: Interview with Jérémy Benattar
15 Mar 2024 Number of shares and voting rights of ADOCIA as of February 29th, 2024 Icon check
06 Mar 2024 ADOCIA Announces Its Participation at Key Events Icon check
Web-conference – 4th Quarter 2023 Financial Results (FR)
Join our mailing list. Subscribe